Skip to main content
ORIENT CEMENT LIMITED logo

ORIENT CEMENT LIMITED — Investor Relations & Filings

Ticker · ORIENTCEM ISIN · INE876N01018 LEI · 335800GWMUH19K5PDZ48 BSE.NS Manufacturing
Filings indexed 1,333 across all filing types
Latest filing 2025-11-01 Regulatory Filings
Country IN India
Listing BSE.NS ORIENTCEM

About ORIENT CEMENT LIMITED

https://orientcement.com/

Orient Cement Limited, a member of the CK Birla Group, focuses on the manufacturing and distribution of cement products. The company operates integrated production facilities and grinding units, utilizing advanced technology to produce Ordinary Portland Cement (OPC) and Pozzolana Portland Cement (PPC). Its primary product line is marketed under the Birla.A1 brand, including specialized variants like Birla.A1 StrongCrete. These products are designed for a wide range of applications, including residential, commercial, and infrastructure development. The company maintains a focus on operational excellence, quality control, and sustainable manufacturing practices, supported by an extensive dealer and distribution network to ensure consistent supply and service across its target markets.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-11-01 English
We are submitting Questions and Answers on the Financial Results of the Company for the quarter and half year ended on 30th September 2025.
Regulatory Filings
2025-11-01 English
Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025.
Regulatory Filings
2025-11-01 English
Outcome of the Board Meeting held on November 1, 2025.
Regulatory Filings
2025-11-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter dated October 17, 2025, addressed to stock exchanges (BSE and NSE) regarding the schedule of an analyst/institutional investor meeting or conference call. It specifically mentions a call on the unaudited financial results for the quarter and half year ended September 30, 2025, scheduled for November 3, 2025. The document is short (4488 characters) and serves as a notice or announcement of the upcoming earnings call rather than containing the financial results or detailed transcript itself. There is no substantive financial data or analysis included, only the schedule and invitation for the call. Therefore, this document is best classified as a Call Transcript (CT) announcement or notice. However, since it is only an intimation of the call schedule and not the transcript itself, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement under SEBI regulations. The document does not contain the actual call transcript or financial report, so it cannot be classified as ER or CT. Given the content and length, the best fit is Regulatory Filings (RNS).
2025-10-17 English
Intimation of Schedule of Analyst / Institutional Investor Meeting /Call scheduled on 03rd November, 2025
Regulatory Filings
2025-10-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.